Incannex announces positive results from phase 2 clinical trial investigating the effect of IHL-42X for treatment of obstructive sleep apnoea ...Middle East

Highlights: IHL-42X reduced primary endpoint apnoea hypopnea index relative to baseline at all three doses that were assessed Low dose IHL-42X exhibited superior safety and efficacy metrics to mid and high doses Low dose IHL-42X reduced AHI by an average of 50.7% compared to baseline with...

Hence then, the article about incannex announces positive results from phase 2 clinical trial investigating the effect of ihl 42x for treatment of obstructive sleep apnoea was published today ( Friday 03/06/2022 - 03:04 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Incannex announces positive results from phase 2 clinical trial investigating the effect of IHL-42X for treatment of obstructive sleep apnoea )

Also on site :

• Lebanese army: Three soldiers, several civilians martyred in bombing accompanying Israeli landing operation in Baalbek
• Democrat Shutdowns Threaten Homeland Security Amid Heightened Threats .. Opinion
• Trump prometió publicar archivos sobre extraterrestres y ovnis. ¿Por qué no lo ha hecho todavía y qué podrían contener?